Inhibition of phosphodiesterase 2 reverses gp91phox oxidase-mediated depression- and anxiety-like behavior-Reference-Cited by-同舟云学术

Inhibition of phosphodiesterase 2 reverses gp91phox oxidase-mediated depression- and anxiety-like behavior

Published:2018-12 Issue: Volume:143 Page:176-185
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Huang Xianfeng,Xiaokaiti Yilixiati,Yang Junqing,Pan Jianchun,Li Zhi,Luria Victor,Li Yunfeng,Song Guoqiang,Zhu Xiongwei^ORCID,Zhang Han-Ting,O'Donnell James M.,Xu Ying

Funder

American Association of Colleges of Pharmacy

University at Buffalo

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference31 articles.

1. Chronic Granulomatous Disease; fundamental stages in our understanding of CGD;Assari;Med. Immunol.,2006

2. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology;Bedard;Physiol. Rev.,2007

3. cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets;Butt;J. Biol. Chem.,1994

4. Phosphodiesterase 2 mediates redox-sensitive endothelial cell proliferation and angiogenesis by thrombin via Rac1 and NADPH oxidase 2;Diebold;Circ. Res.,2009

5. Protective effects of phosphodiesterase 2 inhibitor on depression- and anxiety-like behaviors: involvement of antioxidant and anti-apoptotic mechanisms;Ding;Behav. Brain Res.,2014

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apocynin Prevents Cigarette Smoke-Induced Anxiety-Like Behavior and Preserves Microglial Profiles in Male Mice;Antioxidants;2024-07-16

2. Opportunities and perspectives of small molecular phosphodiesterase inhibitors in neurodegenerative diseases;European Journal of Medicinal Chemistry;2024-05

3. NADPH-oxidases as potential pharmacological targets for thrombosis and depression comorbidity;Redox Biology;2024-04

4. Phosphodiesterase 2 and Its Isoform a as Therapeutic Targets in the Central Nervous System Disorders;CNS & Neurological Disorders - Drug Targets;2023-09-25

5. The potential of esculin as a therapeutic modality in diabetes mellitus and its complications;Human Nutrition & Metabolism;2023-09